§ BIOTECHNOLOGY
USD · BiotechnologyDSGN
DESIGN THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
97 increased/new, 34 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| SR One Capital Management, LP | 6.5M | 7.6% | ±0% |
| Vivo Capital, LLC | 3.2M | n/a | +100% |
| RA CAPITAL MANAGEMENT, L.P. | 3.0M | 0.3% | +103% |
| Point72 | 2.7M | 0.0% | −49% |
| BAKER BROS. ADVISORS LP | 2.6M | 0.2% | +16% |
| BlackRock, Inc. | 2.1M | 0.0% | +1% |
◇ AC INTELLIGENCE
Top institutional owners for DSGN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER29.4% · 0 holders
OTHER56.2% · 77 holders
PASSIVE / INDEX5.3% · 7 holders
DEALER / BANK3.9% · 19 holders
QUALITY / COMPOUNDER2.6% · 8 holders
SYSTEMATIC / QUANT1.1% · 6 holders
ACTIVIST0.8% · 1 holder
TACTICAL / MACRO0.6% · 2 holders
INCOME / DEFENSIVE0.2% · 6 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for DSGN in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention DSGN yet.